Tcc denied as non-formulary by Humana?

Humana's specific coverage criteria for tcc are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Humana Flags Total Contact Casting as Non-Formulary — and How to Appeal

Total contact casting (TCC) is a durable medical equipment and procedural service (CPT 29445 for application; supply codes for casting materials), not a pharmacy benefit drug. When Humana routes TCC through a formulary review and issues a "non-formulary" denial, it typically reflects a benefit-category routing error — the service should be adjudicated under the medical/DME benefit, not the pharmacy formulary. This classification mistake is directly appealable.

## Why This Denial Is Appealable

TCC materials and the application procedure are billed under medical benefit codes, not a drug formulary tier. A non-formulary denial applied to a medical procedure is a category error that does not reflect a valid coverage exclusion. Additionally, Humana's own wound-care medical coverage policies address TCC under the medical benefit. If the denial is actually a medical-benefit denial using "non-formulary" language, the appeal still stands: Humana must demonstrate that its medical coverage policy excludes TCC for patients meeting documented clinical criteria — a high bar given established wound-care society guidance.

## Federal Appeal Framework

• Internal appeal: File within 180 days. For medical/DME benefits, include a written argument that TCC is a medical-benefit service, not a pharmacy-formulary item.
• Expedited appeal: Request if delay poses health risk (active wound deterioration).
• External review (ACA §2719 / ERISA §503): Available after internal exhaustion. An independent reviewer applies clinical standards, not Humana's formulary structure. Act within the ~4-month external-review window from the original denial date.

## Documentation to Gather

1. Benefit-category clarification: A written explanation of benefits (EOB) showing how TCC was routed; a letter to Humana's appeals unit specifying that CPT 29445 is a medical-benefit procedure. 2. Diagnosis and wound documentation: Chart notes confirming the relevant wound type, grade, neuropathic etiology, and absence of contraindications per Humana's wound-care policy. 3. Prior-treatment history: Dates and outcomes of any prior offloading modalities. 4. Prescriber letter: Medical-necessity narrative from the wound-care-credentialed treating provider. 5. Itemized claim: CMS-1500 or UB-04 showing CPT 29445 and relevant diagnosis codes, confirming this is a medical — not pharmacy — claim.

## Criteria-Mapping Structure

Even if the denial is a routing error, proactively address medical-necessity criteria from Humana's wound-care coverage policy:

| Policy or Benefit Requirement | Supporting Documentation | |---|---| | Service is medical-benefit procedure | CPT code + claim form | | Covered wound type and grade | Office note with classification | | Trained/credentialed provider | Credential certificate | | Clinical necessity over removable alternatives | Prescriber letter + prior-treatment log |

Request that Humana's appeals unit confirm which benefit category governs TCC and apply the correct coverage policy. If Humana maintains a formulary-level denial for a medical procedure, that constitutes an arbitrary and capricious coverage determination subject to ERISA challenge.